127 related articles for article (PubMed ID: 38104688)
1. A comprehensive review on structural and therapeutical insight of Cerebroside sulfotransferase (CST) - An important target for development of substrate reduction therapy against metachromatic leukodystrophy.
Singh N; Singh AK
Int J Biol Macromol; 2024 Feb; 258(Pt 1):128780. PubMed ID: 38104688
[TBL] [Abstract][Full Text] [Related]
2. In Silico Structural Modeling and Binding Site Analysis of Cerebroside Sulfotransferase (CST): A Therapeutic Target for Developing Substrate Reduction Therapy for Metachromatic Leukodystrophy.
Singh N; Singh AK
ACS Omega; 2024 Mar; 9(9):10748-10768. PubMed ID: 38463293
[TBL] [Abstract][Full Text] [Related]
3. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of cerebroside analogues as substrates of cerebroside sulphotransferase and discovery of a competitive inhibitor.
Li W; Guillaume J; Baqi Y; Wachsmann I; Gieselmann V; Van Calenbergh S; Müller CE
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1503-1512. PubMed ID: 32657203
[TBL] [Abstract][Full Text] [Related]
5. Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy.
Eckhardt M; Hedayati KK; Pitsch J; Lüllmann-Rauch R; Beck H; Fewou SN; Gieselmann V
J Neurosci; 2007 Aug; 27(34):9009-21. PubMed ID: 17715338
[TBL] [Abstract][Full Text] [Related]
6. The role and metabolism of sulfatide in the nervous system.
Eckhardt M
Mol Neurobiol; 2008; 37(2-3):93-103. PubMed ID: 18465098
[TBL] [Abstract][Full Text] [Related]
7. Glial Sulfatides and Neuronal Complex Gangliosides Are Functionally Interdependent in Maintaining Myelinating Axon Integrity.
McGonigal R; Barrie JA; Yao D; McLaughlin M; Cunningham ME; Rowan EG; Willison HJ
J Neurosci; 2019 Jan; 39(1):63-77. PubMed ID: 30446529
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology of sulfatide metabolism in metachromatic leukodystrophy].
Wiesmann UN
Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):33-47. PubMed ID: 27269
[TBL] [Abstract][Full Text] [Related]
9. Novel molecular insights into the critical role of sulfatide in myelin maintenance/function.
Palavicini JP; Wang C; Chen L; Ahmar S; Higuera JD; Dupree JL; Han X
J Neurochem; 2016 Oct; 139(1):40-54. PubMed ID: 27417284
[TBL] [Abstract][Full Text] [Related]
10. A capillary electrophoresis method with dynamic pH junction stacking for the monitoring of cerebroside sulfotransferase.
Li W; Zech I; Gieselmann V; Müller CE
J Chromatogr A; 2015 Aug; 1407():222-7. PubMed ID: 26163931
[TBL] [Abstract][Full Text] [Related]
11. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
[TBL] [Abstract][Full Text] [Related]
12. Elucidating the Therapeutic Utility of Olaparib in Sulfatide-Induced Human Astrocyte Toxicity and Neuroinflammation.
Mekhaeil M; Conroy MJ; Dev KK
J Neuroimmune Pharmacol; 2023 Dec; 18(4):592-609. PubMed ID: 37924373
[TBL] [Abstract][Full Text] [Related]
13. Sulfatide decrease in myelin influences formation of the paranodal axo-glial junction and conduction velocity in the sciatic nerve.
Hayashi A; Kaneko N; Tomihira C; Baba H
Glia; 2013 Apr; 61(4):466-74. PubMed ID: 23322453
[TBL] [Abstract][Full Text] [Related]
14. Fetal metachromatic leukodystrophy: pathology, biochemistry and a study of in vitro enzyme replacement in CNS tissue.
Poduslo SE; Tennekoon G; Price D; Miller K; McKhann GM
J Neuropathol Exp Neurol; 1976; 35(6):622-32. PubMed ID: 11278
[TBL] [Abstract][Full Text] [Related]
15. Structure and composition of sulfatides isolated from livers of patients with metachromatic leukodystrophy: galactosyl sulfatide and lactosyl sulfatide.
Sugita M; Dulaney JT; Moser HW
J Lipid Res; 1974 May; 15(3):227-33. PubMed ID: 4363968
[TBL] [Abstract][Full Text] [Related]
16. Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy.
Givogri MI; Galbiati F; Fasano S; Amadio S; Perani L; Superchi D; Morana P; Del Carro U; Marchesini S; Brambilla R; Wrabetz L; Bongarzone E
J Neurosci; 2006 Mar; 26(12):3109-19. PubMed ID: 16554462
[TBL] [Abstract][Full Text] [Related]
17. Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.
Babcock MC; Mikulka CR; Wang B; Chandriani S; Chandra S; Xu Y; Webster K; Feng Y; Nelvagal HR; Giaramita A; Yip BK; Lo M; Jiang X; Chao Q; Woloszynek JC; Shen Y; Bhagwat S; Sands MS; Crawford BE
Sci Rep; 2021 Jul; 11(1):14486. PubMed ID: 34262084
[TBL] [Abstract][Full Text] [Related]
18. Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder.
Saravanan K; Schaeren-Wiemers N; Klein D; Sandhoff R; Schwarz A; Yaghootfam A; Gieselmann V; Franken S
Neurobiol Dis; 2004 Jul; 16(2):396-406. PubMed ID: 15193296
[TBL] [Abstract][Full Text] [Related]
19. Sulfatides in prenatal metachromatic leukodystrophy.
Baier W; Harzer K
J Neurochem; 1983 Dec; 41(6):1766-8. PubMed ID: 6644310
[TBL] [Abstract][Full Text] [Related]
20. Biochemical pathogenesis of genetic leukodystrophies: comparison of metachromatic leukodystrophy and globoid cell leukodystrophy (Krabbe's disease).
Suzuki K
Neuropediatrics; 1984 Sep; 15 Suppl():32-6. PubMed ID: 6152811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
